← Leaderboards
Steven M Scharf
University Of Maryland Baltimore
$3,091,621
Attributed
$3,091,621
Total exposure
13
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $681.3K · FY2005–09$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
Funding mix
By agency
NIH$3,091,621 · 13
By mechanism
U10$2,649,689 · 1
M01$441,932 · 12
Top collaborators
No co-investigators on record.
Most similar at University Of Maryland Baltimore
Same institution · by research overlap
- Arik V Marcell$6,762,484
- Cynthia L Renn$2,214,813
- Susan G Dorsey$16,761,780
- Marcela F Pasetti$26,884,335
- Wayne Chienhwa Wang$1,121,250
Others in their field
Top investigators on “Resources”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$688,986,350
- Bambra Strokes · Ppd Development Lp$526,656,217
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Eric S Lander · Whitehead Institute For Biomedical Res$341,717,134
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$311,514,701
Research focus
ResourcesFundingUnited States National Institutes Of HealthChronic Obstructive Airway DiseaseInstitutionGrantResearch PersonnelSourceComputer Retrieval Of Information On Scientific Projects DatabaseClinical TrialsClinical ResearchBloodSeveritiesPrednisoloneMonoclonal AntibodyHospitalizationRespiratory Disease /Disorder TherapyChronic Obstructive Pulmonary DiseasePatient Oriented ResearchOxygenPlacebosMacrolidesAzithromycinMacrolide Antibiotics
Grant awards (17)
CLINICAL TRIAL: EFFECT OF CHRONIC MACROLIDE ADMINISTRATION ON COPD EXACERBATIONS$160,181
M01 · FY2009 · RR · contact PI
CLINICAL TRIAL: PNEUMOCOCCAL VACCINE RESPONSE IN COPD$24,508
M01 · FY2009 · RR · contact PI
CLINICAL TRIAL: ANTI-LEUKOTRIENE THERAPY FOR COPD EXACERBATIONS$11,378
M01 · FY2009 · RR · contact PI
CLINICAL TRIAL: EFFECT OF CHRONIC MACROLIDE ADMINISTRATION ON COPD EXACERBATIONS$114,803
M01 · FY2008 · RR · contact PI
CLINICAL TRIAL: PNEUMOCOCCAL VACCINE RESPONSE IN COPD$24,672
M01 · FY2008 · RR · contact PI
COLLECTION OF BLOOD FOR FUTURE GENETIC TESTING$4,532
M01 · FY2008 · RR · contact PI
CLINICAL TRIAL: ANTI-LEUKOTRIENE THERAPY FOR COPD EXACERBATIONS$4,029
M01 · FY2008 · RR · contact PI
THE EFFECT OF CHRONIC MACROLIDE ADMINISTRATION ON THE FREQUENCY AND SEVERITY$42,435
M01 · FY2007 · RR · contact PI
Clinical Center-COPD Clinical Research Network$675,324
U10 · FY2006 · HL · contact PI
A TRIAL TO COMPARE TWO METHODS OF DELIVERING OXYGEN TO COPD PATIENTS$4,951
M01 · FY2006 · RR · contact PI
INFLIXIMAB FOR TREATMENT OF COPD - A PILOT STUDY$985
M01 · FY2006 · RR · contact PI
Clinical Center-COPD Clinical Research Network$555,982
U10 · FY2005 · HL
INFLIXIMAB FOR TREATMENT OF COPD - A PILOT STUDY$26,030
M01 · FY2005 · RR
A TRIAL TO COMPARE TWO METHODS OF DELIVERING OXYGEN TO COPD PATIENTS$634
M01 · FY2005 · RR
Clinical Center-COPD Clinical Research Network$626,808
U10 · FY2004 · HL
Infliximab Treatment for COPD-A Pilot Study$22,794
M01 · FY2004 · RR
Clinical Center-COPD Clinical Research Network$791,575
U10 · FY2003 · HL